Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Case Reports in Oncology|June 15, 2022
Treatment Response Monitoring Using a Tumor-Informed Circulating Tumor DNA Test in an Advanced Triple-Negative Breast Cancer Patient: A Case ReportGeorges Azzi, Shifra Krinshpun, Antony Tin, et al.Frontiers in Oncology|August 13, 2024
Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphomaMayur Narkhede, Sarah Tomassetti, Madiha Iqbal, et al.JCO Precision Oncology|May 5, 2025
Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients With Metastatic Invasive Lobular Carcinoma of the BreastJulia Foldi, Steffi Oesterreich, Antony Tin, et al.JCO Precision Oncology|January 8, 2025
Detecting Early Recurrence With Circulating Tumor DNA in Stage I-III Biliary Tract Cancer After Curative ResectionJames Yu, Aiwu Ruth He, Mahmoud Ouf, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2025
Circulating Tumor DNA Longitudinal Analysis During Total Neoadjuvant Therapy and Non-operative Management for Locally Advanced Rectal Cancer: A Biomarker Study from the NOMINATE TrialTakashi Akiyoshi, Eiji Shinozaki, Yusuke Maeda, et al.Molecular Oncology|December 1, 2023
Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumorsEkaterina Kalashnikova, Vasily N Aushev, Allyson Koyen Malashevich, et al.JCO Precision Oncology|July 2, 2025
Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular CarcinomaMaen Abdelrahim, Alejandro Mejia, Abdullah Esmail, et al.Nature|October 20, 2025
Neoadjuvant immunotherapy in mismatch-repair-proficient colon cancersPedro B Tan, Yara L Verschoor, José G van den Berg, et al.Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Longitudinal ctDNA Surveillance in Older Women with ER+ Breast Cancer to Facilitate Surgical De-Escalation: A Prospective, Hybrid-Decentralized Trial with Correlative StudiesNeil Carleton, Alexander C Chang, Fangyuan Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2026
Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative StudiesNeil Carleton, Alexander C Chang, Fangyuan Chen, et al.Pageof 2